Retrospective Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. Jun 7, 2019; 25(21): 2650-2664
Published online Jun 7, 2019. doi: 10.3748/wjg.v25.i21.2650
Table 2 Demographic and clinical characteristics of the clinically relevant postoperative pancreatic fistula and non-clinically relevant postoperative pancreatic fistula groups, n (%)
Variablenon-CR-POPF (n = 237)CR-POPF (n = 61)P-value
Age (yr)61.8 ± 10.162.2 ± 9.40.804
Sex0.095
Male135 (57.0)41 (67.2)
Female102 (43.0)20 (32.8)
Surgery0.445
PD123 (51.9)35 (57.4)
PPPD114 (48.1)26 (42.6)
BMI (kg/m2)22.0 ± 2.922.5 ± 2.80.352
Diabetes mellitus0.351
Yes42 (17.7)14 (23.0)
No195 (82.3)47 (77.0)
Location of tumor0.131
Pancreas130 (54.9)40 (65.6)
Non-pancreas107 (45.1)21 (34.4)
Pathologic type0.428
Benign13 (5.5)5 (8.2)
Malignant224 (94.5)56 (91.8)
Preoperative STB (μmol/L)106.0 ± 120.0132.8 ± 120.90.221
Preoperative pre-albumin (mg/L)143.1 ± 56.2133.7 ± 60.70.364
Preoperative serum albumin (g/L)39.1 ± 5.435.9 ± 6.30.002
Preoperative serum globulin (g/L)26.9 ± 4.327.2 ± 3.30.675
Preoperative hemoglobin (g/L)122.1 ± 18.3118.6 ± 25.20.339
Preoperative white blood cells (109/L)7.0 ± 8.96.7 ± 2.10.833
Preoperative platelets (109/L)236.3 ± 83.5223.2 ± 54.10.358
Pancreatic texture< 0.001
Soft80 (33.8)50 (82.0)
Hard157 (66.2)11 (18.0)
Main pancreatic duct diameter (mm)3.2 ± 1.02.6±0.70.001
Biliary tract compression31 (13.1)7 (11.5)0.738
Pancreaticojejunostomy anastomosis0.201
Duct-to-mucosa180 (75.9)51 (83.6)
Dunking method57 (24.1)10 (16.4)
Pancreatic duct stent0.052
Internal stent99 (41.8)36 (59.0)
External stent88 (37.1)15 (24.6)
None50 (21.1)10 (16.4)
Vascular invasion0.272
Yes40 (16.9)14 (23.0)
No197 (83.1)47 (77.0)
Operative time (min)267.9 ± 68.7275.9 ± 76.90.531
Estimated blood loss (mL)287.4 ± 229.3451.3 ± 365.10.001
Serum albumin POD 1 (g/L)33.03 ± 5.232.9 ± 5.90.918
Serum globulin on POD 1 (g/L)23.5 ± 11.923.0 ± 4.90.832
Hemoglobin on POD 1 (g/L)111.2 ± 17.3114.9 ± 14.30.236